Our pursuit of science-based drug discovery.
As “the world’s leading innovators who deliver advanced medicines to patients with intractable diseases”, our mission is to harness the power of science to swiftly deliver seeds for novel medicines needed by patients.
- Features
Drawing upon a strong foundation in small molecule drug discovery, we have spearheaded the development of a multitude of pipeline products, catalyzing the creation of new pharmaceuticals.
To propel our growth, we actively pursue drug discovery utilizing innovative modalities, fostering an environment of open innovation.
At RaQualia Pharma, we leverage an array of cutting-edge platform technologies specifically designed for small molecule drug discovery. Our suite of technologies remains at the forefront of innovation, spanning from advanced electrophysiological techniques for ion channel research to state-of-the-art methodologies for next-generation drug discovery.
To swiftly apply new insights and technologies to drug discovery, we promote synergistic co-creation with partners, such as academia, startups, and venture companies, to build a next-generation drug discovery value chain.